AUDREY BAKER: Open Payments
NPI 1598296972 · NEW LEXINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 107 payments from 24 companies in 2025. Trend: 2023 $1,748 · 2024 $1,895 · 2025 $1,555
Food & beverage: $1,510Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $452 |
| Currax Pharmaceuticals LLC | 19 | $213 |
| Lilly USA, LLC | 7 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| Corcept Therapeutics | 5 | $95 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| PFIZER INC. | 2 | $37 |
| Exact Sciences Corporation | 2 | $35 |
Products named: VRAYLAR, CONTRAVE, CAPLYTA, UBRELVY, QULIPTA, Korlym, SHINGRIX, MOUNJARO.
Industry payments across OH — which companies pay providers there.
